Kadmon Corporation to Present at the JMP Securities Healthcare Conference
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 07/09/12 -- , today announced that Samuel D. Waksal, Ph.D., Chairman and Chief Executive Officer of Kadmon, will present at the JMP Securities Healthcare Conference on Thursday, July 12th at 1:00 p.m. Eastern Time at the Peninsula Hotel in New York City. Dr. Waksal will provide an overview of Kadmon and its commercial and clinical programs.
A live audio webcast of the presentation will be accessible through Kadmon's website at . The webcast will be archived for 90 days.
Kadmon Corporation, LLC is a global company built on a 21st-century paradigm for the translation of innovative science into treatment. The company currently offers products and services for the treatment and management of hepatitis C. Kadmon is pioneering medicines in oncology, infectious diseases, immunology and neurodegenerative diseases by using emerging concepts in molecular biology and genomics to develop therapies that target the metabolomics and signaling pathways associated with disease. For more information, visit .
For Kadmon Corporation:
David Pitts
Argot Partners
212.600.1902
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 09.07.2012 - 12:00 Uhr
Sprache: Deutsch
News-ID 163140
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 148 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Kadmon Corporation to Present at the JMP Securities Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Kadmon Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
